The global enoxolone market is expected to grow at a significant CAGR during the forecast period (2021-2027). One of the major bioactive components of liquorice is enoxolone (glycyrrhizic acid), a pentacyclic triterpenoid aglycone metabolite of glycyrrhizin. It's often used in medicine to treat chronic dermatitis and peptic ulcers, as well as in cosmetics. Antibacterial, antifungal, antiprotozoal, and antiviral activities are among its other pharmacological characteristics. When enoxolone is given, it prevents both prostaglandin reductase and 15-hydroxyprostaglandin dehydrogenase [NAD(+)] from metabolizing prostaglandins.

Free Sample Copy @ https://www.omrglobal.com/request-sample/enoxolone-market

Due to changes in lifestyle and unhealthy eating habits, the number of individuals suffering from chronic diseases is rising. This, in turn, supports the global enoxolone market's growth. In the US, for instance, 4.6 million instances of peptic ulcers are reported each year. The global market is expected to grow as the prevalence of chronic dermatitis rises. Eczema is quite prevalent, especially among youngsters and those who suffer from hay fever, asthma, or food allergies. According to the National Eczema Association, over 10% of Americans, or 31.6 million people, suffer from eczema.

A Full Report of Global Enoxolone Market is Available at:
https://www.omrglobal.com/industry-reports/enoxolone-market

Furthermore, rising research funding, government initiatives to improve healthcare facilities, and a focus on research are all anticipated to drive the global enoxolone market's growth. In the global enoxolone market, the rise in incidence and awareness of chronic illnesses, as well as government efforts in developing countries, provide attractive prospects.

In both developing and developed nations, the demand for enoxolone has grown. To extend their footprint, market companies are employing third-party distributors. As a result, the number of distributors and suppliers in developing countries has increased dramatically. This opens up a significant market potential. For instance, Selleck Chemicals provides approximately 120,000 inhibitors for the research of cell signalling networks. BioVision, Inc. has a robust distribution channel in Argentina, Australia, Belgium, Brazil, Canada, China, the Czech Republic, Denmark, France, and Germany.

Global Enoxolone Market – Segmentation
By Type
Oral
Tropical
By Application
Chronic Dermatitis
Eczema
Frostbite
Peptic Ulcer
Antitussive
By Distribution Channel
Online Pharmacy
Hospital Pharmacy
Retail Stores

Global Enoxolone Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Merck KGaA (Sigma-Aldrich, Inc.)
Alchem International Pvt. Ltd.
Biosynth Carbosynth
BioVision Inc.
Tokiwa Phytochemical Co.Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/enoxolone-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404